- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
High-dose vitamin D not tied to adverse events in kids upto 6 years of age: JAMA
Denmark: In children aged 0 to 6 years, high-dose vitamin D supplementation was not linked with an increased risk of severe adverse events (SAEs), and clinical adverse events probably due to the supplementation were infrequent, says an article published in the Journal of American Medical Association.
Several health advantages of vitamin D have been proposed; yet, the safety of high-dose administration in early development is unknown. As a result, Nicklas Brustad and colleagues undertook this investigation to comprehensively examine the likelihood of adverse events after high-dose vitamin D supplementation described in published randomized clinical trials.
ClinicalTrials.gov and PubMed were searched for this study until August 24, 2021. The study required randomized trials of high-dose vitamin D administration in children aged 0 to 6 years, defined as higher than 1000 IU/d for babies (aged 0-1 year) and greater than 2000 IU/d for children aged 1 to 6 years. Serious adverse events (SAEs), adverse events, and/or levels of 25-hydroxyvitamin D, alkaline phosphatase, calcium, parathyroid hormone, phosphate, and/or urine calcium-to-creatinine ratio.
The key findings of this study were as follows:
1. A total of 32 randomized clinical trials with a total of 8400 unique individuals were included in the study.
2. The clinical effects of children who received high-dose vitamin D supplements ranging from 1200 to 10 000 IU/d and bolus doses ranging from 30 000 IU/week to a single dose of 600 000 IU were studied.
3. When assessing the risk of SAEs such as hospitalization or death, eight trials involving 4612 individuals were qualified for meta-analysis, with a control group receiving either low-dose vitamin D supplementation (400 IU/d) or placebo.
4. There was no overall higher risk of SAEs in the high-dose vitamin D groups compared to the control groups.
5. Furthermore, the risk of hypercalcemia (n = 726) was not raised. Clinical side effects possibly related to vitamin D administration were seldom documented in the trials.
In conclusion, these findings imply that high-dose vitamin D supplementation for children between the ages of 0 to 6 years may be a safe supplement method for a variety of health outcomes.
Reference: Brustad N, Yousef S, Stokholm J, Bønnelykke K, Bisgaard H, Chawes BL. Safety of High-Dose Vitamin D Supplementation Among Children Aged 0 to 6 Years: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(4):e227410. doi:10.1001/jamanetworkopen.2022.7410
Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751